@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_head { this: np:hasAssertion dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_assertion; np:hasProvenance dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_provenance; np:hasPublicationInfo dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_publicationInfo; a np:Nanopublication . dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_assertion a np:Assertion . dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_provenance a np:Provenance . dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_publicationInfo a np:PublicationInfo . } dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_assertion { miriam-gene:10950 a ncit:C16612 . lld:C0553662 a ncit:C7057 . dgn-gda:DGNb5455aaa5b3bd791d31a2b00cc48db9b sio:SIO_000628 miriam-gene:10950, lld:C0553662; a sio:SIO_001121 . } dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_provenance { dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_assertion dcterms:description "[On the basis of these criteria the following five JCA groups and their subgroups were included in the study: (1) define systemic onset (n = 25) and systemic progressing to persistent arthritis (n = 14); (2) JCA of oligoarthritis onset (O-JCA, n = 124) and of oligoarthritis onset and course (n = 98), O-JCA of early (< 6 years) or late (> 6 years) onset (EOO-JCA n = 71 and LOO-JCA n = 44), O-JCA with ANA positive (n = 69) or negative (n = 55) and O-JCA progressing to extended arthritis (n = 22); (3) JCA of polyarthritis onset (P-JCA) with rheumatic factor (RF) negative (n = 29), and P-JCA RF negative with antinuclear antibodies (ANA) positive (n = 13) or negative (n = 16); (4) JCA complicated with chronic anterior uveitis (CAU, n = 32); (5) juvenile psoriatic arthritis (n = 20).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:10457895; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP910778.RAFmaaF9XEv17lqAI5mX6Nsw7oGrvstO3aIC4cqmNTivM130_publicationInfo { this: dcterms:created "2014-10-02T12:41:19+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }